Hydro Air Wellness Lab
- PRP Therapy
- Shockwave Therapy
- Arthritis Treatment
- Cryotherapy
- Red Light Therapy
Gilbert, AZ
Stem-cell therapy in Gilbert splits along East Valley corridors. Interventional and orthopedic-adjacent rooms sit nearer Downtown Gilbert / Heritage District soft-tissue demand. Cash-pay longevity menus cluster on SanTan Village medical storefronts. Val Vista / Loop 202 Santan Freeway suites catch the same label with different tissue sources.
Same "stem cell" label can mean same-day bone marrow or adipose product, a birth-tissue marketing pitch, or an investigational protocol. Those products are not interchangeable.
This hub lists Directory clinics for Gilbert and stem-cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask tissue or cell source, same-day autologous vs allogeneic, who performs the procedure, imaging guidance, what outcomes they track, how adverse events are handled, and whether the marketing matches FDA product category. Queen Creek and Mesa show up as drive time for some patients. ASU Poly / Phoenix-Mesa Gateway adjacency is geography only. Prefer plain risk talk. Use the national stem-cell Directory and Guide, then return here.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
In Arizona, cellular products are governed by federal rules under 21 CFR Part 1271. Products that are minimally manipulated and used for homologous use fall under Section 361 and do not require premarket approval. Products that are more than minimally manipulated, used non-homologously, or combined with another article are regulated as biological drugs under Section 351 and require an Investigational New Drug application or Biologics License Application. Most adipose-derived stromal vascular fraction and culture-expanded stem cell procedures marketed for orthopedic, neurologic, or longevity indications are Section 351 products.
The FDA has issued warning letters and untitled letters to stem cell providers operating in Arizona for marketing unapproved biological products. Arizona is home to several high-profile regenerative clinics, and FDA inspections in the state have cited violations of current good manufacturing practice and unapproved drug claims. The Arizona Medical Board has disciplined physicians for unprofessional conduct tied to misleading advertising of stem cell outcomes. No statewide injunction parallel to the US v California Stem Cell Treatment Center case has been issued in Arizona, but enforcement exposure remains elevated.
Available here
Nationwide
Stem Cell Therapy clinics across the US